Vandana Rai

Prof. Vandana Rai


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

9 July 2014 in Metabolic Brain Disease
Verified
Journal Article
Closed access
PDF file
UYUpendra Yadav
Upendra Yadav
PKPradeep Kumar
Pradeep Kumar
SYSushil Kumar Yadav
Sushil Kumar Yadav
OMOm Prakash Mishra
Om Prakash Mishra
VRVandana Rai
Vandana Rai

1 April 2016 in Asian Journal of Psychiatry
Verified
Journal Article
Closed access
UYUpendra Yadav
Upendra Yadav
PKPradeep Kumar
Pradeep Kumar
SGSanjay Gupta
Sanjay Gupta
VRVandana Rai
Vandana Rai


29 September 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
VRVandana Rai
Vandana Rai
UYUpendra Yadav
Upendra Yadav
PKPradeep Kumar
Pradeep Kumar
SYSushil Kumar Yadav
Sushil Kumar Yadav
OMOm Prakesh Mishra
Om Prakesh Mishra
Methylenetetrahydrofolate reductase (MTHFR) is a key enzyme of folate metabolic pathway which catalyzes the irreversible conversion of 5, 10-methylenetetrahydrofolate to 5-methyltetrahydrofolate. 5-methyltetrahydrofolate donates methyl group for the methylation of homocysteine to methionine. Several studies have investigated maternal MTHFR C677T polymorphism as a risk factor for DS, but the results were controversial and inconclusive. To come into a conclusive estimate, authors performed a meta-analysis. A meta-analysis of published case control studies was performed to investigate the association between maternal MTHFR C677T polymorphism and Down syndrome. PubMed, Google Scholar, Elsevier, Springer Link databases were searched to select the eligible case control studies using appropriate keywords. The pooled odds ratio (OR) with 95%confidence interval were calculated for risk assessment. Thirty four studies with 3,098 DS case mothers and 4,852 control mothers were included in the present meta-analysis. The pooled OR was estimated under five genetic models and significant association was found between maternal MTHFR 677C>T polymorphism and Down syndrome under four genetic models except recessive model (for T vs. C, OR = 1.26, 95% CI = 1.09–1.46, p = 0.001; for TT vs. CC, OR = 1.49, 95% CI = 1.13–1.97, p = 0.008; for CT vs. CC, OR = 1.29, 95% CI = 1.10–1.51, p = 0.001; for TT+CT vs. CC, OR = 1.35, 95% CI = 1.13–1.60, p = 0.0008; for TT vs. CT+CC, OR = 0.76, 95% CI = 0.60–0.94, p = 0.01). The results of the present meta-analysis support that maternal MTHFR C677T polymorphism is a risk factor for DS- affected pregnancy.

11 October 2016 in Indian Journal of Clinical Biochemistry
Verified
Journal Article
Closed access
PDF file
UYUpendra Yadav
Upendra Yadav
PKPradeep Kumar
Pradeep Kumar
SGSanjay Gupta
Sanjay Gupta
VRVandana Rai
Vandana Rai